ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,196.88
0.29%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Nuo Therapeutics Inc (QB) (AURX)

  7. Nuo Therapeutics Inc (QB) (AURX) News

Nuo Therapeutics (QB) (AURX)

Nuo Therapeutics Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:AURX
DateTimeSourceHeadlineSymbolCompany
11/06/202421:26Edgar (US Regulatory)Form 8-K - Current reportUSOTC:AURXNuo Therapeutics Inc (QB)
22/05/202417:40Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:AURXNuo Therapeutics Inc (QB)
21/05/202420:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
21/05/202420:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
21/05/202413:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:AURXNuo Therapeutics Inc (QB)
15/05/202422:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:AURXNuo Therapeutics Inc (QB)
14/02/202418:58Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsUSOTC:AURXNuo Therapeutics Inc (QB)
12/02/202422:33Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:AURXNuo Therapeutics Inc (QB)
22/12/202315:01Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:AURXNuo Therapeutics Inc (QB)
20/12/202319:18Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:AURXNuo Therapeutics Inc (QB)
20/12/202319:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
20/12/202319:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
20/12/202314:02Edgar (US Regulatory)Form 8-K - Current reportUSOTC:AURXNuo Therapeutics Inc (QB)
20/11/202321:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:AURXNuo Therapeutics Inc (QB)
15/11/202314:37Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:AURXNuo Therapeutics Inc (QB)
08/08/202319:15Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:AURXNuo Therapeutics Inc (QB)
03/08/202321:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
03/08/202321:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
03/08/202321:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:AURXNuo Therapeutics Inc (QB)
15/05/202322:10Edgar (US Regulatory)Quarterly Report (10-q)USOTC:AURXNuo Therapeutics Inc (QB)
17/04/202311:08Edgar (US Regulatory)Annual Report (10-k)USOTC:AURXNuo Therapeutics Inc (QB)
14/11/202223:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AURXNuo Therapeutics Inc (QB)
04/11/202221:28Edgar (US Regulatory)Quarterly Report (10-q)USOTC:AURXNuo Therapeutics Inc (QB)
20/10/202213:36Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:AURXNuo Therapeutics Inc (QB)
20/10/202213:34Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:AURXNuo Therapeutics Inc (QB)
30/08/202213:16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:AURXNuo Therapeutics Inc (QB)
10/08/202218:29Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:AURXNuo Therapeutics Inc (QB)
08/08/202221:49Edgar (US Regulatory)Quarterly Report (10-q)USOTC:AURXNuo Therapeutics Inc (QB)
05/07/202213:03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:AURXNuo Therapeutics Inc (QB)
05/07/202213:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:AURXNuo Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:AURX

Your Recent History

LSE
PANR
Pantheon Resources
LSE
AAZ
Anglo Asian Mining
LSE
INSG
Insig Ai
LSE
ENET
Ethernity Networks
LSE
SBTX
Skinbiotherapeutics
LSE
GPM
Golden Prospect Precious...
LSE
SDRY
Superdry
LSE
HUM
Hummingbird Resources
LSE
SRSP
Sirius Petroleum
LSE
PHNX
Phoenix
LSE
GOLD
LSE
VOD
Vodafone
LSE
LLOY
Lloyds Banking
LSE
AFC
Afc Energy
LSE
CNR
Condor Gold
LSE
BT.A
Bt
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved